{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:59Z","timestamp":1792787279594,"version":"4.5.0"},"reference-count":33,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Senju Pharmaceutical Co., Ltd.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/0135fer63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Juntendo University Department of Ophthalmology Alumni Fund.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/01692sz90","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2026,9,17]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjophth-2026-002799","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:19Z","timestamp":1792061719000},"page":"e002799","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Non-inferiority study of the efficacy of ranibizumab BS compared with aflibercept in patients with macular oedema due to untreated branch retinal vein occlusion: REMEDY-BRVO study \u2013 study protocol"],"prefix":"10.1136","volume":"11","author":[{"given":"Ai","family":"Toride","sequence":"first","affiliation":[{"name":"Juntendo University, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ashikaga","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo Daigaku - Hongo Campus, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutaro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo Daigaku - Hongo Campus, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University - Hongo Campus, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Ouchi-Usui","sequence":"additional","affiliation":[{"name":"Ophthalmology, Juntendo University Urayasu Hospital, Urayasu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhide","family":"Takesue","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University Nerima Hospital, Nerima, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Ishida","sequence":"additional","affiliation":[{"name":"Ophthalmology, Ishida Eye Clinic, Joetsu, Niigata Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Sadamatsu","sequence":"additional","affiliation":[{"name":"Ophthalmology, Sadamatsu Eye Clinic, Kasukabe, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Adachi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Adachi Eye Clinic, Kazo, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-2740","authenticated-orcid":false,"given":"Koichi","family":"Ono","sequence":"additional","affiliation":[{"name":"Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Takami","sequence":"additional","affiliation":[{"name":"Senju Pharmaceutical Co Ltd Kobe Creative Center, Kobe, Hyogo Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tajika","sequence":"additional","affiliation":[{"name":"Senju Pharmaceutical Co Ltd Kobe Innovative Center, Kobe, Hyogo Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hirakata","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University Nerima Hospital, Nerima, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimune","family":"Hiratsuka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University - Hongo Campus, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-0052","authenticated-orcid":false,"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Juntendo University - Hongo Campus, Bunkyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2026101503551143000_11.4.e002799.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.01.058"},{"key":"2026101503551143000_11.4.e002799.2","doi-asserted-by":"crossref","unstructured":"Rogers S , McIntosh RL , Cheung N , et al . The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117. doi:10.1016\/j.ophtha.2009.07.017%5Bpublished","DOI":"10.1016\/j.ophtha.2009.07.017"},{"key":"2026101503551143000_11.4.e002799.3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4453"},{"key":"2026101503551143000_11.4.e002799.4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7775"},{"key":"2026101503551143000_11.4.e002799.5","doi-asserted-by":"crossref","unstructured":"Chan CM , Hsiao CY , Li HJ , et al . The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells. Int J Mol Sci 2019;21. doi:10.3390\/ijms21010109%5Bpublished","DOI":"10.3390\/ijms21010109"},{"key":"2026101503551143000_11.4.e002799.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.02.038"},{"key":"2026101503551143000_11.4.e002799.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.035"},{"key":"2026101503551143000_11.4.e002799.8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","article-title":"Individualized stabilization criteria\u2013driven ranibizumab versus laser in branch retinal vein occlusion","volume":"123","author":"Tadayoni","year":"2016","journal-title":"Ophthalmology"},{"key":"2026101503551143000_11.4.e002799.9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.survophthal.2025.05.008","article-title":"Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: a systematic review and network meta-analysis of randomized controlled trials","volume":"70","author":"Chen","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10384-019-00685-4","article-title":"Current practice in the management of branch retinal vein occlusion in Japan: survey results of retina specialists in Japan","volume":"63","author":"Ogura","year":"2019","journal-title":"Jpn J Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41598-020-79051-1","article-title":"The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naive patients","volume":"11","author":"Murata","year":"2021","journal-title":"Sci Rep"},{"key":"2026101503551143000_11.4.e002799.12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10384-020-00785-6","article-title":"Twenty-four-month results of intravitreal aflibercept for macular edema due to branch retinal vein occlusion","volume":"65","author":"Sakanishi","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-020-00758-9"},{"key":"2026101503551143000_11.4.e002799.14","first-page":"785","article-title":"Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview","volume":"Online First","author":"Semeraro","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2026101503551143000_11.4.e002799.15","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.ophtha.2016.06.053","article-title":"Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial infarction, stroke, and death","volume":"123","author":"Yashkin","year":"2016","journal-title":"Ophthalmology"},{"key":"2026101503551143000_11.4.e002799.16","doi-asserted-by":"crossref","unstructured":"Umeya R , Yoshida Y , Ono K . Impact of retinal vein occlusion on cardiovascular events in elderly Japanese patients. Medicine (Baltimore) 2021;100. doi:10.1097\/MD.0000000000028424%5Bpublished","DOI":"10.1097\/MD.0000000000028424"},{"key":"2026101503551143000_11.4.e002799.17","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.2"},{"key":"2026101503551143000_11.4.e002799.18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40942-024-00606-9","article-title":"Is retinal vein occlusion highly associated with an increased risk of myocardial infarction? A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2024","journal-title":"Int J Retina Vitreous"},{"key":"2026101503551143000_11.4.e002799.19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10384-025-01170-x","article-title":"Longitudinal renal function changes during real-world anti-vascular endothelial growth factor therapy for diabetic macular edema in Japan","volume":"69","author":"Usui-Ouchi","year":"2025","journal-title":"Jpn J Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10384-024-01134-7","article-title":"First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration","volume":"69","author":"Lee","year":"2025","journal-title":"Jpn J Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305252"},{"key":"2026101503551143000_11.4.e002799.22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","article-title":"Clinical pharmacology of intravitreal anti-VEGF drugs","volume":"32","author":"Fogli","year":"2018","journal-title":"Eye (Lond)"},{"key":"2026101503551143000_11.4.e002799.23","doi-asserted-by":"crossref","first-page":"118881","DOI":"10.1016\/j.biopha.2025.118881","article-title":"Comparative effectiveness and safety landscape of anti-VEGF therapies for neovascular age-related macular degeneration: Insights from a systematic review and network meta-analysis","volume":"196","author":"Chen","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"2026101503551143000_11.4.e002799.24","doi-asserted-by":"publisher","DOI":"10.1167\/IOVS.15-17814"},{"key":"2026101503551143000_11.4.e002799.25","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.ajoc.2019.100549","article-title":"Branch retinal artery occlusion in the untreated contralateral eye following aflibercept injections during heparin treatment: Possible contribution of a heparin-induced thrombocytopenia-like condition","volume":"Online First","author":"Nakao","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2026101503551143000_11.4.e002799.26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10384-025-01254-8","article-title":"Six-month comparative outcomes of aflibercept and faricimab in treatment-naive macular edema secondary to branch retinal vein occlusion","volume":"70","author":"Hikichi","year":"2026","journal-title":"Jpn J Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.27","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.86"},{"key":"2026101503551143000_11.4.e002799.28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamaophthalmol.2020.5053","article-title":"Efficacy and safety of a proposed ranibizumab biosimilar product vs a reference ranibizumab product for patients with neovascular age-related macular degeneration","volume":"139","author":"Woo","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41433-022-02246-5","article-title":"Approved biosimilar ranibizumab-a global update","volume":"37","author":"Sharma","year":"2023","journal-title":"Eye (Lond)"},{"key":"2026101503551143000_11.4.e002799.30","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s40123-022-00588-7","article-title":"Three monthly injections versus one initial injection of ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion: 12-month results of a prospective randomized study","volume":"Online First","author":"Tang","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"2026101503551143000_11.4.e002799.31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12886-020-01498-7","article-title":"Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial","volume":"Online First","author":"Song","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.32","doi-asserted-by":"crossref","first-page":"e1503","DOI":"10.1111\/aos.15182","article-title":"Navigated laser and aflibercept versus aflibercept monotherapy in treatment-naive branch retinal vein occlusion: a 12-month randomized trial","volume":"100","author":"Frederiksen","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"2026101503551143000_11.4.e002799.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.12.034"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2026-002799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:26Z","timestamp":1792061726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2026-002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10,15]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjophth-2026-002799"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2026-002799","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}